Cargando…

Impact of adjuvant therapeutic surgery on the health-related quality of life of pulmonary tuberculosis patients

This study aimed to determine the health-related quality of life (HRQoL) of patients with pulmonary tuberculosis (TB) and to assess its change after a therapeutic surgical procedure. In this scenario, the purpose was to elucidate and quantify the effect of various demographic, epidemiological, clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benito, Pau, Vashakidze, Sergo, Gogishvili, Shota, Nikolaishvili, Keti, Despuig, Albert, Tukvadze, Nestan, Shubladze, Natalia, Avaliani, Zaza, Vilaplana, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456644/ https://www.ncbi.nlm.nih.gov/pubmed/32904577 http://dx.doi.org/10.1183/23120541.00083-2020

Ejemplares similares

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia
por: Vashakidze, Sergo, et al.
Publicado: (2016)

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections
por: Moreno-Molina, Miguel, et al.
Publicado: (2021)

Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis
por: Vashakidze, Sergo A., et al.
Publicado: (2019)

A case report of persistent drug-sensitive pulmonary tuberculosis after treatment completion
por: Vashakidze, Sergo A., et al.
Publicado: (2022)

Does optimized adherence support improve treatment outcomes in RR / MDR-TB patients on 18–20 months regimen in Tbilisi, Georgia?
por: Jomidava, Tinatin, et al.
Publicado: (2021)

Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils
por: Fonseca, Kaori L., et al.
Publicado: (2020)

Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU-VNTR typing
por: Maghradze, Nino, et al.
Publicado: (2019)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

HIV co-infection increases the risk of post-tuberculosis mortality among patients treated for drug resistant tuberculosis
por: Salindri, Argita D., et al.
Publicado: (2023)

Tuberculosis recovery in Georgia: implementing more by 24
por: Kiria, Nana, et al.
Publicado: (2022)

The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis
por: Chan, Conrad E., et al.
Publicado: (2015)

Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
por: Lomtadze, Nino, et al.
Publicado: (2013)

SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen
por: Arias, Lilibeth, et al.
Publicado: (2023)

Plasma Metabolomics in Human Pulmonary Tuberculosis Disease: A Pilot Study
por: Frediani, Jennifer K., et al.
Publicado: (2014)

Long-term Follow-up Reveals High Posttreatment Mortality Rate Among Patients With Extensively Drug-Resistant Tuberculosis in the Country of Georgia
por: Frank, Melanie, et al.
Publicado: (2019)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019–2020
por: Avaliani, Teona, et al.
Publicado: (2021)

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis
por: Maranchick, Nicole F., et al.
Publicado: (2022)

The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot
por: Loiseau, Chloé, et al.
Publicado: (2023)

Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
por: Enriquez, Ana B., et al.
Publicado: (2021)

Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis
por: Kipiani, Maia, et al.
Publicado: (2021)

Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis
por: Moreira-Teixeira, Lúcia, et al.
Publicado: (2020)

Pulmonary Tuberculosis, Etiological and Therapeutic
Publicado: (1891)

Pulmonary Tuberculosis: General Therapeutics
Publicado: (1894)

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
por: Mbuagbaw, Lawrence, et al.
Publicado: (2019)

Factors associated with loss to follow-up among people with tuberculosis in the country of Georgia: a cohort study
por: Adamashvili, Natalia, et al.
Publicado: (2021)

Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance
por: Evans, Emily E., et al.
Publicado: (2022)

Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients
por: Shamkuwar, Chetna Ashok, et al.
Publicado: (2017)

C. burnetii Shedding Study In Domestic Animals in Georgia
por: Nikolaishvili, Marine
Publicado: (2019)

Prophylactic Effect of a Therapeutic Vaccine against TB Based on Fragments of Mycobacterium tuberculosis
por: Vilaplana, Cristina, et al.
Publicado: (2011)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
por: Kempker, Russell R., et al.
Publicado: (2015)

Pulmonary Tuberculosis: Its Etiology, Symptomatology, and Therapeutics
Publicado: (1889)

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines
por: Gomez, Gabriela Beatriz, et al.
Publicado: (2021)

Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study
por: Suárez-Méndez, Roberto, et al.
Publicado: (2004)

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
por: Baldwin, Susan L., et al.
Publicado: (2022)

High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans
por: Collins, Jeffrey M., et al.
Publicado: (2018)

TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis
por: Collins, Jeffrey M., et al.
Publicado: (2021)

Diagnostic and Therapeutic Problems of Pulmonary Tuberculosis in Elderly Patients
por: Lee, Jae Ho, et al.
Publicado: (2005)

A New Therapeutic Agent in the Treatment of Pulmonary Tuberculosis
por: Warren, Sevier
Publicado: (1913)

Adjuvant Efficacy of Nutrition Support During Pulmonary Tuberculosis Treating Course: Systematic Review and Meta-analysis
por: Si, Zhuang-Li, et al.
Publicado: (2015)

Developing customized stepwise MIRU-VNTR typing for tuberculosis surveillance in Georgia
por: Maghradze, Nino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b45jql7knb6e96te96gih7ccbq